Metraipolis › archive › dc_ec3d2007741f

Therapeutic Drug Monitoring and Point-of-Care Technologies: Opportunities and Current Challenges — Europe PMC PMID:40990332

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40990332
DOI
10.1097/ftd.0000000000001384
License (as archived)
solo-consultazione
Archived
2026-11-09T12:48:35.095Z
SHA-256 of the archived text
0fe7602e50326385380a6046690de21f42332d9e82807171a7deef86742c117a
Stable URL of this page
https://metraipolis.com/documento/dc_ec3d2007741f

How to cite

Therapeutic Drug Monitoring and Point-of-Care Technologies: Opportunities and Current Challenges — Europe PMC PMID:40990332 — Europe PMC (en), https://europepmc.org/article/MED/40990332 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ec3d2007741f (Metraipolis archive dc_ec3d2007741f, sha256 0fe7602e50326385380a6046690de21f42332d9e82807171a7deef86742c117a)
BibTeX
@misc{dcec3d2007741f,
  title = {Therapeutic Drug Monitoring and Point-of-Care Technologies: Opportunities and Current Challenges — Europe PMC PMID:40990332},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40990332},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ec3d2007741f; sha256 0fe7602e50326385380a6046690de21f42332d9e82807171a7deef86742c117a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40990332. Agents can read the archived copy with the MCP tool read_document.